Table II.
Clinicopathological factors of 100 colorectal cancer patients with high (n=56) and low (n=44) levels of ANXA9 mRNA expression.
| Factors | Low expression, n (%) | High expression, n (%) | P-value |
|---|---|---|---|
| Age, years | |||
| <68 | 25 (56.8) | 27 (48.2) | 0.392 |
| ≥68 | 19 (43.2) | 29 (51.8) | |
| Gender | |||
| Male | 24 (54.5) | 37 (66.1) | 0.244 |
| Female | 20 (45.5) | 19 (33.9) | |
| Histological grade | |||
| Well-moderate | 41 (93.2) | 55 (98.2) | 0.202 |
| Poor | 3 (6.8) | 1 (1.8) | |
| Tumor size, mm | |||
| <30 | 8 (18.2) | 9 (16.1) | 0.780 |
| ≥30 | 36 (81.8) | 47 (83.9) | |
| Tumor invasion | |||
| Tis | 4 (9.1) | 3 (5.4) | 0.316 |
| T1 | 7 (15.9) | 6 (10.7) | |
| T2 | 9 (20.4) | 6 (10.7) | |
| T3 | 19 (43.2) | 28 (50.0) | |
| T4 | 5 (11.4) | 13 (23.2) | |
| Lymph node metastasis | |||
| N0 | 31 (70.5) | 33 (58.9) | 0.233 |
| N1–2 | 13 (29.5) | 23 (41.1) | |
| Lymphatic invasion | |||
| Absent | 20 (45.5) | 26 (46.4) | 0.824 |
| Present | 24 (54.5) | 30 (53.6) | |
| Venous invasion | |||
| Absent | 33 (75.0) | 42 (75.0) | 1.000 |
| Present | 11 (25.0) | 14 (25.0) | |
| Metastasis | |||
| M0 | 38 (86.4) | 50 (89.3) | 0.655 |
| M1 | 6 (13.6) | 6 (10.7) | |
| UICC stage | |||
| 0-I | 17 (38.6) | 13 (23.2) | 0.221 |
| II | 13 (29.5) | 18 (32.1) | |
| IIIA | 4 (9.1) | 14 (25.0) | |
| IIIB | 4 (9.1) | 5 (8.9) | |
| IV | 6 (13.6) | 6 (10.7) | |
ANXA9, annexin A9; UICC, International Union Against Cancer.